Gut Liver.
2022 Nov;16(6):807-808. 10.5009/gnl220414.
Bismuth-Based Quadruple Therapy for Clarithromycin-Resistant Helicobacter pylori Infection: Effectiveness and Cost-Efficiency
- Affiliations
-
- 1Department of Internal Medicine, Pusan National University College of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
- KMID: 2535184
- DOI: http://doi.org/10.5009/gnl220414
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Management of Helicobacter pylori Infection in Europe: Focusing on the Maastricht V/Florence Consensus
- Bismuth-Based Quadruple Therapy versus MetronidazoleIntensified Triple Therapy as a First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial
- Recent Trends of Helicobacter pylori Eradication Therapy: Focusing on First Line Treatment
- Current Trends of Helicobacter pylori Eradication in Korea
- Current Strategies for Eradication of Helicobacter pylori in Korea
